Investor Proehl Gerald T
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Proehl Gerald T . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-04-07 13D/A DRMA / Dermata Therapeutics, Inc. 233,030 804,098
2025-04-03 13D/A 804,098
2025-02-13 13D/A DRMA.W / Dermata Therapeutics, Inc. - Equity Warrant
2025-01-23 13D/A 803,751
2023-03-30 13D/A DRMA / Dermata Therapeutics, Inc. 3,721,035 233,030
2023-01-18 13D/A DRMA / Dermata Therapeutics, Inc. 3,658,445 3,721,035
2022-05-05 13D/A DRMA / Dermata Therapeutics, Inc. 3,331,309 3,658,445
2021-08-27 13D DRMA / Dermata Therapeutics, Inc. 3,331,309